Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment

Justine L. Kuiper, Daniëlle A.M. Heideman, Tom Würdinger, Katrien Grünberg, Harry J.M. Groen, Egbert F. Smit

Clinical Lung Cancer · 2014 · 13 citations · 36 references

DOIFull text

Open access

Concepts

References

36